Cost segregation data for Cambridge, MA (Kendall Square) investors
Interquartile range across 50 engine-modeled property scenarios matched to the Cambridge, MA (Kendall Square) investor profile. Year-1 savings shown are the federal benefit (37% + 3.8% NIIT). This state does not conform to federal bonus depreciation, so the state share is not accelerated; it recovers over standard MACRS.
Representative scenarios modeled via Cost Seg Smart's proprietary
engine — IRS ATG-aligned methodology, industry-standard 2026 construction cost data base costs,
calibrated metro multipliers. n=50 fixtures matched to
Cambridge, MA (Kendall Square) investor profile. Not derived from individual
client returns. Methodology v1.0.0, generated
May 2026 (reproducible seed: cambridge-ma_v1_2026-05-17).
Year-1 savings shown are the federal benefit only (37% + 3.8% NIIT). This state does not conform to federal §168(k) bonus depreciation, so the state share is deferred over standard MACRS rather than realized in Year 1; the federal benefit is unaffected. Confirm specifics with your CPA.
Tax law current as of May 2026. Federal: OBBBA restored 100% bonus depreciation under §168(k), permanent for property placed in service on or after January 20, 2025 (property placed in service January 1–19, 2025 remains at 40% under the prior phase-down); 2026+ stays 100%. State conformity varies; verify with your CPA.
If you earn a W-2 in Cambridge biotech, at MIT, or anywhere in the Kendall Square cluster, and your household crosses $1M, you trigger the Massachusetts Millionaire’s Tax (4% surcharge stacked on top of 5% base). Combined federal + state runs ~50%. Cost segregation on out-of-state STR is the highest-leverage tax move at that bracket.
- $168,000 Accelerated Depreciation (typical coastal Maine STR worked example)
- $69,000 Est. Year-1 Tax Savings (37% + 3.8% NIIT; MA portion deferred over MACRS)
- 69x Return on Study Cost
Want a number for your specific situation? Use the calculator — preset for property-type defaults you can adjust to your basis and bracket.
Who are Cambridge biotech cost segregation investors?
Cambridge’s cost-seg buyer pool is biotech-dominant in a way no other US metro is:
- Big-biotech executives + senior research (Moderna Kendall Square HQ, Vertex, Biogen, Sanofi, Takeda Boston, Pfizer Cambridge, Bristol-Myers Squibb Cambridge) — $400K–$2M+ with equity vesting
- MIT + Harvard faculty and senior researchers with commercialization equity stakes — $300K–$1M+ with bio-IP licensing income
- Pre-IPO biotech founders + senior employees (Cambridge has dozens of $1B+ biotech pre-IPOs at any given time) — $250K–$800K base + significant equity
- VC and biotech equity (Flagship Pioneering, Atlas Venture, Third Rock — biotech-specialist firms) — $400K–$2M+ with carry on portfolio liquidation events
The combined marginal-rate stack:
- Under $1M household income: Federal 37% + NIIT 3.8% + MA 5% = ~46% combined
- Over $1M household income (Millionaire’s Tax triggered): Federal 37% + NIIT 3.8% + MA 9% = ~50% combined
Cambridge biotech execs typically cross $1M in vesting / liquidity event years, making the Millionaire’s Tax surcharge a routine line item — and cost-seg timing against those events particularly valuable.
Verify with your CPA — combined-rate math depends on filing status, AGI thresholds for NIIT, and the actual MA Millionaire’s Tax computation.
Why cost seg pays more if you live in Cambridge
A typical $600K–$1.2M out-of-state STR reclassifies 24–32% of basis under permanent 100% bonus depreciation. Massachusetts does not conform to federal §168(k) bonus depreciation, so the state share of the deduction is deferred over standard 5/7/15-year MACRS rather than taken in Year 1; the federal Year-1 benefit is unaffected. See bonus depreciation by state. At the federal top bracket plus NIIT (37% + 3.8% = ~40.8%), every $1 of accelerated depreciation is worth ~$0.408 federally in Year-1 cash savings.
The Cambridge biotech advantage is liquidity timing: vesting cliffs, IPO secondary sales, and milestone-payment events generate large taxable income spikes — exactly the years when accelerated depreciation produces maximum value. Time the deduction against a vesting year and the effective Year-1 return on a cost-seg study is exceptional.
Where do Cambridge investors buy property?
Cambridge investors flow capital to vacation markets within a 2-hour drive or flight:
- Coastal Maine (Kennebunkport, Camden, Bar Harbor) — Closest premium STR, 2-hour drive. ME 7.15% state tax stack adds modestly.
- Cape Cod, Nantucket, Martha’s Vineyard — Atlantic vacation; underwrite local STR rules carefully.
- Charleston, SC — Historic coastal, year-round occupancy.
- Smoky Mountains (Pigeon Forge) — Tennessee 0% state tax, cabin STR.
- Naples, FL — Premium Gulf Coast STR, FL 0% state tax.
Many Cambridge investors also pursue REPS-via-spouse on Boston-metro long-term rentals (Newton, Brookline, Cambridge multifamily). Boston’s older 2-3 family housing stock makes 2-4 unit LTR a parallel play, but requires REPS qualification (typically via non-W-2 spouse).
A real Cambridge investor’s worked example
A Moderna VP earning $1.4M (mix of base + RSU vesting), residing in Cambridge MA, buys a 3BR coastal Maine cottage in Kennebunkport for $800K with $25K immediate FF&E refresh. After $200K in land, the $600K adjusted basis includes $72K in 5-year assets (kitchen appliances, smart-home, theater system, coastal-living package, decorative lighting), $24K in 7-year assets (custom furniture, coastal-themed built-ins), and $72K in 15-year property (deck, fencing, gravel drive, outdoor shower, landscaping).
That’s $168K reclassified into accelerated depreciation in Year 1. At the federal top bracket plus NIIT (37% + 3.8% NIIT; MA portion deferred over MACRS), Year-1 federal savings come to roughly $69,000. The MA state share is not lost, it is simply spread over the standard MACRS schedules rather than taken in Year 1. If the deduction is timed against a Moderna RSU vesting cliff, the effective offset against vesting-year income is significant.
Who doesn’t qualify for cost segregation in Cambridge?
REPS is structurally impossible for a full-time biotech executive or senior research scientist — the 750-hour + >50% test conflicts with lab and clinical hours. The STR exception (Reg. §1.469-1T(e)(3)(ii), 7-day average stay + 100-hour material participation) is the alternative path.
For Cambridge biotech investors managing a Maine or Cape Cod STR remotely, the 100-hour material participation requirement means active management — communicating with guests, scheduling cleanings, managing the listing. The 2-hour drive to coastal Maine is short enough that monthly on-site visits + active remote management typically clears the threshold.
Frequently Asked Questions
How much does a cost segregation study cost in Cambridge? For a typical $800,000 Cambridge investment property, a Cost Seg Smart study runs $995. Full pricing: $495 (under $300K), $895 ($300K–$700K), $995 ($700K–$1M), $1,295 ($1M–$1.5M), $1,595 ($1.5M–$2M), $1,995 ($2M–$3M), $2,495 ($3M–$4M), $3,995 ($4M–$6M), $5,995 ($6M–$8M), $7,995 ($8M–$10M). Commercial and 5+ unit multifamily studies start at $1,995; 2–4 unit multifamily from $795. All studies delivered in under one hour with the CPA-Ready Guarantee — full refund if your CPA can’t use the report.
Does MA conform to federal bonus depreciation? Massachusetts does not conform to federal §168(k) bonus depreciation. The federal Year-1 deduction is fully available; the Massachusetts share is not accelerated and recovers over standard 5/7/15-year MACRS (deferred, not lost). Confirm specifics with your CPA. Note that bonus depreciation does NOT directly reduce the MA AGI base used for the Millionaire’s Tax surcharge calculation in all cases.
How is Cambridge different from Boston for cost-seg purposes? Tax-wise, identical — both pay MA’s Millionaire’s Tax stack at the top. The difference is buyer profile: Cambridge skews biotech + academic + pre-IPO; Boston skews finance + medicine + senior tech. The cost-seg deduction-timing strategy (against vesting cliffs and IPO/milestone events) is more aggressive in Cambridge’s biotech profile.
What about Cambridge multifamily for LTR cost-seg? Cambridge + Somerville have strong 2-3 family stock. LTR cost-seg works at standard 27.5-year residential schedules with 18-22% typical reclass. The economics depend on REPS (which requires a non-W-2 spouse for full benefit) — feasible in many Cambridge dual-career biotech-academic households where one spouse has flexible hours.
Learn More About Cost Segregation
- What Is Cost Segregation?
- STR Tax Exception Explained
- Cost Segregation in Boston — Adjacent Boston investor page
- Real Estate Professional Status
How should Cambridge, MA (Kendall Square) investors choose a cost segregation provider?
For a Cambridge, MA (Kendall Square) investor buying a property in the $800,000 range, the choice of study provider is the single biggest controllable variable in the ROI. The methodology is fixed by IRS Audit Techniques Guide rules (industry-standard construction cost data, MACRS classification, engineering-based component reclassification) — what varies is delivery cost and turnaround time.
Traditional engineering studies often run several thousand dollars and can take several weeks, because they include on-site inspections, sales discovery calls, and scheduling overhead. The IRS Cost Segregation Audit Techniques Guide does not require a physical site visit; it requires engineering-based classification with industry-calibrated cost derivation and component-level documentation.
Modern automated providers (such as Cost Seg Smart) deliver the same IRS ATG–aligned study for $495–$1,595 in under one hour, using satellite imagery, county assessor data, and the same industry-standard construction cost databases. For a Cambridge, MA (Kendall Square) investor at the metro's combined bracket, that cost delta typically exceeds the study cost itself by several times over. The CPA-Ready Guarantee (full refund if the report can't be used by your CPA) plus the 60-day money-back policy makes the decision essentially risk-free on the report itself.
The automated path is best-fit for Cambridge, MA (Kendall Square) investors who: own residential STR property valued under $2M, are comfortable uploading closing docs + property photos online (no in-person visit required), and want the report in time to file the current year's return rather than the next one.
| Property value | Cost Seg Smart | Traditional firm |
|---|---|---|
| <$300K | $495 | Traditional engineering firms typically charge several thousand dollars per study, with a 4–8 week turnaround and an on-site visit. |
| $300K–$700K | $895 | |
| $700K–$1M | $995 | |
| $1M–$1.5M | $1,295 | |
| $1.5M–$2M | $1,595 | |
| $2M–$3M | $1,995 | |
| Commercial (under $1M) | $1,995 |
All Cost Seg Smart studies include the CPA-Ready Guarantee (full refund if your CPA can't use the report) plus a 60-day money-back policy. Reports are delivered in under one hour with no on-site visit required.